2021

1. CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia

   CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535

2. Future approaches for treating chronic myeloid leukemia: Crispr therapy

   Biology, Vol. 10, Núm. 2, pp. 1-16